Hanna Björkelund
Publications by Year
Research Areas
Monoclonal and Polyclonal Antibodies Research, HER2/EGFR in Cancer Research, Glycosylation and Glycoproteins Research, Protein purification and stability, Advanced Biosensing Techniques and Applications
Most-Cited Works
- → NRP1 Presented in trans to the Endothelium Arrests VEGFR2 Endocytosis, Preventing Angiogenic Signaling and Tumor Initiation(2014)97 cited
- → Gefitinib Induces Epidermal Growth Factor Receptor Dimers Which Alters the Interaction Characteristics with 125I-EGF(2011)84 cited
- → Comparing the Epidermal Growth Factor Interaction with Four Different Cell Lines: Intriguing Effects Imply Strong Dependency of Cellular Context(2011)53 cited
- → CD14 Mediates Binding of High Doses of LPS but Is Dispensable for TNF-αProduction(2013)50 cited
- → Deciphering complex protein interaction kinetics using Interaction Map(2012)49 cited
- → Multivalent Fcγ-receptor engagement by a hexameric Fc-fusion protein triggers Fcγ-receptor internalisation and modulation of Fcγ-receptor functions(2017)48 cited
- → Resolving the EGF-EGFR interaction characteristics through a multiple-temperature, multiple-inhibitor, real-time interaction analysis approach(2012)35 cited
- → Selection and in vitro characterization of human CD44v6‐binding antibody fragments(2012)31 cited
- → The non-toxic and biodegradable adjuvant Montanide ISA 720/CpG can replace Freund's in a cancer vaccine targeting ED-B—a prerequisite for clinical development(2011)27 cited
- → Avidity characterization of genetically engineered T-cells with novel and established approaches(2016)18 cited